Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images

ObjectivesMetachronous liver metastasis (LM) significantly impacts the prognosis of stage I-III colorectal cancer (CRC) patients. An effective biomarker to predict LM after surgery is urgently needed. We aimed to develop deep learning-based models to assist in predicting LM in stage I-III CRC patien...

Full description

Bibliographic Details
Main Authors: Chanchan Xiao, Meihua Zhou, Xihua Yang, Haoyun Wang, Zhen Tang, Zheng Zhou, Zeyu Tian, Qi Liu, Xiaojie Li, Wei Jiang, Jihui Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.844067/full
_version_ 1818309089298481152
author Chanchan Xiao
Chanchan Xiao
Meihua Zhou
Xihua Yang
Haoyun Wang
Zhen Tang
Zheng Zhou
Zeyu Tian
Qi Liu
Xiaojie Li
Wei Jiang
Wei Jiang
Jihui Luo
author_facet Chanchan Xiao
Chanchan Xiao
Meihua Zhou
Xihua Yang
Haoyun Wang
Zhen Tang
Zheng Zhou
Zeyu Tian
Qi Liu
Xiaojie Li
Wei Jiang
Wei Jiang
Jihui Luo
author_sort Chanchan Xiao
collection DOAJ
description ObjectivesMetachronous liver metastasis (LM) significantly impacts the prognosis of stage I-III colorectal cancer (CRC) patients. An effective biomarker to predict LM after surgery is urgently needed. We aimed to develop deep learning-based models to assist in predicting LM in stage I-III CRC patients using digital pathological images.MethodsSix-hundred eleven patients were retrospectively included in the study and randomly divided into training (428 patients) and validation (183 patients) cohorts according to the 7:3 ratio. Digital HE images from training cohort patients were used to construct the LM risk score based on a 50-layer residual convolutional neural network (ResNet-50). An LM prediction model was established by multivariable Cox analysis and confirmed in the validation cohort. The performance of the integrated nomogram was assessed with respect to its calibration, discrimination, and clinical application value.ResultsPatients were divided into low- and high-LM risk score groups according to the cutoff value and significant differences were observed in the LM of the different risk score groups in the training and validation cohorts (P<0.001). Multivariable analysis revealed that the LM risk score, VELIPI, pT stage and pN stage were independent predictors of LM. Then, the prediction model was developed and presented as a nomogram to predict the 1-, 2-, and 3-year probability of LM. The integrated nomogram achieved satisfactory discrimination, with C-indexes of 0.807 (95% CI: 0.787, 0.827) and 0.812 (95% CI: 0.773, 0.850) and AUCs of 0.840 (95% CI: 0.795, 0.885) and 0.848 (95% CI: 0.766, 0.931) in the training and validation cohorts, respectively. Favorable calibration of the nomogram was confirmed in the training and validation cohorts. Integrated discrimination improvement and net reclassification index indicated that the integrated nomogram was superior to the traditional clinicopathological model. Decision curve analysis confirmed that the nomogram has clinical application value.ConclusionsThe LM risk score based on ResNet-50 and digital HE images was significantly associated with LM. The integrated nomogram could identify stage I-III CRC patients at high risk of LM after primary colectomy, so it may serve as a potential tool to choose the appropriate treatment to improve the prognosis of stage I-III CRC patients.
first_indexed 2024-12-13T07:24:37Z
format Article
id doaj.art-62ae1439024f44308c460f2ad1d7d12a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T07:24:37Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-62ae1439024f44308c460f2ad1d7d12a2022-12-21T23:55:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.844067844067Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological ImagesChanchan Xiao0Chanchan Xiao1Meihua Zhou2Xihua Yang3Haoyun Wang4Zhen Tang5Zheng Zhou6Zeyu Tian7Qi Liu8Xiaojie Li9Wei Jiang10Wei Jiang11Jihui Luo12Department of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of Microbiology and Immunology, Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of Surgical Oncology, Chenzhou No. 1 People’s Hospital, Chenzhou, ChinaDepartment of Microbiology and Immunology, Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of Pathology, Chenzhou No. 1 People’s Hospital, Chenzhou, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaDepartment of Surgical Oncology, Chenzhou No. 1 People’s Hospital, Chenzhou, ChinaDepartment of General Surgery, Hunan Provincial People’s Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, ChinaObjectivesMetachronous liver metastasis (LM) significantly impacts the prognosis of stage I-III colorectal cancer (CRC) patients. An effective biomarker to predict LM after surgery is urgently needed. We aimed to develop deep learning-based models to assist in predicting LM in stage I-III CRC patients using digital pathological images.MethodsSix-hundred eleven patients were retrospectively included in the study and randomly divided into training (428 patients) and validation (183 patients) cohorts according to the 7:3 ratio. Digital HE images from training cohort patients were used to construct the LM risk score based on a 50-layer residual convolutional neural network (ResNet-50). An LM prediction model was established by multivariable Cox analysis and confirmed in the validation cohort. The performance of the integrated nomogram was assessed with respect to its calibration, discrimination, and clinical application value.ResultsPatients were divided into low- and high-LM risk score groups according to the cutoff value and significant differences were observed in the LM of the different risk score groups in the training and validation cohorts (P<0.001). Multivariable analysis revealed that the LM risk score, VELIPI, pT stage and pN stage were independent predictors of LM. Then, the prediction model was developed and presented as a nomogram to predict the 1-, 2-, and 3-year probability of LM. The integrated nomogram achieved satisfactory discrimination, with C-indexes of 0.807 (95% CI: 0.787, 0.827) and 0.812 (95% CI: 0.773, 0.850) and AUCs of 0.840 (95% CI: 0.795, 0.885) and 0.848 (95% CI: 0.766, 0.931) in the training and validation cohorts, respectively. Favorable calibration of the nomogram was confirmed in the training and validation cohorts. Integrated discrimination improvement and net reclassification index indicated that the integrated nomogram was superior to the traditional clinicopathological model. Decision curve analysis confirmed that the nomogram has clinical application value.ConclusionsThe LM risk score based on ResNet-50 and digital HE images was significantly associated with LM. The integrated nomogram could identify stage I-III CRC patients at high risk of LM after primary colectomy, so it may serve as a potential tool to choose the appropriate treatment to improve the prognosis of stage I-III CRC patients.https://www.frontiersin.org/articles/10.3389/fonc.2022.844067/fulldeep learningcolorectal cancermetachronous liver metastasisprediction modelnomogram
spellingShingle Chanchan Xiao
Chanchan Xiao
Meihua Zhou
Xihua Yang
Haoyun Wang
Zhen Tang
Zheng Zhou
Zeyu Tian
Qi Liu
Xiaojie Li
Wei Jiang
Wei Jiang
Jihui Luo
Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
Frontiers in Oncology
deep learning
colorectal cancer
metachronous liver metastasis
prediction model
nomogram
title Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
title_full Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
title_fullStr Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
title_full_unstemmed Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
title_short Accurate Prediction of Metachronous Liver Metastasis in Stage I-III Colorectal Cancer Patients Using Deep Learning With Digital Pathological Images
title_sort accurate prediction of metachronous liver metastasis in stage i iii colorectal cancer patients using deep learning with digital pathological images
topic deep learning
colorectal cancer
metachronous liver metastasis
prediction model
nomogram
url https://www.frontiersin.org/articles/10.3389/fonc.2022.844067/full
work_keys_str_mv AT chanchanxiao accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT chanchanxiao accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT meihuazhou accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT xihuayang accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT haoyunwang accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT zhentang accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT zhengzhou accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT zeyutian accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT qiliu accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT xiaojieli accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT weijiang accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT weijiang accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages
AT jihuiluo accuratepredictionofmetachronouslivermetastasisinstageiiiicolorectalcancerpatientsusingdeeplearningwithdigitalpathologicalimages